Beta Therapeutics
Latest round
- Seed
Last raised
- Jun 2018
Total raised
- $0.6M
Investors
- 1
About Beta Therapeutics
Beta Therapeutics is an Australian biotechnology company developing first in class treatments for diseases driven by inflammation in micro-environments including retinopathy, diabetes, tumor growth and metastasis.
Who invested in Beta Therapeutics
1 investor across 1 round
See all investors in Beta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 15, 2018
Amount
$0.6M
Investors
Questions about Beta Therapeutics
Who invested in Beta Therapeutics?
Beta Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beta Therapeutics raised?
Beta Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beta Therapeutics last raise money?
Beta Therapeutics's most recent round on record is a Seed, in Jun 2018.
What does Beta Therapeutics do?
Beta Therapeutics is an Australian biotechnology company developing first in class treatments for diseases driven by inflammation in micro-environments including retinopathy, diabetes, tumor growth and metastasis.
Where is Beta Therapeutics headquartered?
Beta Therapeutics is headquartered in Canberra, Australia.
Which VCs invest in companies like Beta Therapeutics?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Beta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Beta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.